Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts $4.32 +0.20 (+4.85%) As of 05/9/2025 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Kezar Life Sciences Earnings Summary Kezar Life Sciences announced Q4 2024 & Study Result earnings on March 25, 2025, reporting an EPS of -$2.77, which missed the consensus estimate of -$2.71 by $0.06. With a trailing EPS of -$11.55, Kezar Life Sciences' earnings are expected to decrease next year, from ($4.39) to ($8.31) per share. Latest Q4 2024 & Study Result Earnings DateMar. 25EstimatedConsensus EPS (Mar. 25) -$2.71 Actual EPS (Mar. 25) -$2.77 Missed By -$0.06 Q4 2024 & Study Result Earnings ResourcesQ4 2024 & Study Result Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K) Slide DeckSEC FilingSlide DeckFull Screen Slide DeckPowered by Get Kezar Life Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kezar Life Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKZR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Kezar Life Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$2.73-$2.56-$2.65Q2 20252-$2.75-$2.57-$2.66Q3 20252-$2.78-$2.59-$2.69Q4 20252-$2.80-$2.61-$2.71 FY 2025 8 -$11.06 -$10.33 -$10.70 Q1 20261-$2.95-$2.95-$2.95Q2 20261-$3.03-$3.03-$3.03Q3 20261-$3.10-$3.10-$3.10Q4 20261-$3.16-$3.16-$3.16 Kezar Life Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/25/2025Q4 2024 & Study Result-$2.71-$2.77 -$0.06-$2.77--11/12/2024--$3.03-$2.78+$0.25-$2.78$4.00M-8/13/2024Q2 2024-$3.20-$2.80+$0.40-$0.26--5/9/2024Q1 2024-$3.40-$3.00+$0.40-$0.30--3/14/2024Q4 2023-$3.90-$3.50+$0.40-$0.26--11/13/2023Q3 2023-$3.60-$3.20+$0.40-$0.32$0.50M$7.00M8/10/2023Q2 2023-$3.30-$3.40 -$0.10-$0.34--5/11/2023Q1 2023-$2.80-$3.10 -$0.30-$0.31-- Kezar Life Sciences Earnings - Frequently Asked Questions When did Kezar Life Sciences announce their last quarterly earnings? Kezar Life Sciences (NASDAQ:KZR) last announced its quarterly earning data on Tuesday, March 25, 2025. Learn more on KZR's earnings history. Did Kezar Life Sciences beat their earnings estimates last quarter? In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) missed the analysts' consensus estimate of ($2.71) by $0.06 with a reported earnings per share (EPS) of ($2.77). Learn more on analysts' earnings estimate vs. KZR's actual earnings. How can I listen to Kezar Life Sciences's earnings conference call? The conference call for Kezar Life Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Kezar Life Sciences's conference call transcript? The conference call transcript for Kezar Life Sciences's latest earnings report can be read online. Read Transcript How can I view Kezar Life Sciences's earnings report? Kezar Life Sciences's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded annual revenue of $7 million. How much profit does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$11.55 earnings per share over the last four quarters. What is Kezar Life Sciences's EPS forecast for next year? Kezar Life Sciences's earnings are expected to decrease from ($4.39) per share to ($8.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies scPharmaceuticals Earnings Sol-Gel Technologies Earnings Compugen Earnings RAPT Therapeutics Earnings Coherus BioSciences Earnings Silence Therapeutics Earnings Enanta Pharmaceuticals Earnings Alector Earnings C4 Therapeutics Earnings Atossa Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:KZR) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMAY 14: New IPO 350X Bigger Than Amazon IPO?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredThis robot is coming to 65 million Americans … this year.The Robotics Revolution has arrived. And not surprisingly, Nvidia is leading the way. Nvidia CEO Jensen ...Weiss Ratings | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kezar Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kezar Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.